29 Jul 2025
🐾FDA Notice on Compounding Animal Drugs from Bulk Substances
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Compounding Animal Drugs From Bulk Drug Substances
Summary
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The text outlines regulatory requirements for animal drug compounding, highlighting potential compliance costs and operational changes for businesses involved in veterinary services. Businesses must adhere to FDA regulations, facing legal ramifications if not complied with. The emphasis on documentation and processes may also impact operational burdens.